GKB Ophthalmics Ltd Stock Price Today (NSE: GKB)
Fundamental Score
GKB Ophthalmics Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
GKB Ophthalmics Ltd share price today is ₹60.70, down 2.21% on NSE/BSE as of 18 June 2026. GKB Ophthalmics Ltd (GKB) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹29.99 (Cr). The 52-week high for GKB share price is ₹91.70 and the 52-week low is ₹45.25. The company has a Return on Equity (ROE) of -12.66% and a debt-to-equity ratio of 0.28.
GKB Ophthalmics Ltd Share Price Chart — NSE/BSE Historical Performance
GKB Ophthalmics Ltd share price chart: -3.70% return over the past month. 52-week high ₹91.70, 52-week low ₹45.25.
GKB Ophthalmics Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹63.15 | ₹63.15 | ₹60.60 | ₹60.70 | 913.00 (Cr) | |
| ₹63.73 | ₹63.73 | ₹62.07 | ₹62.07 | 56.00 (Cr) | |
| ₹62.00 | ₹64.50 | ₹62.00 | ₹63.73 | 1.25K (Cr) | |
| ₹67.85 | ₹70.35 | ₹64.50 | ₹65.00 | 7.33K (Cr) | |
| ₹67.20 | ₹69.50 | ₹66.92 | ₹67.85 | 7.05K (Cr) | |
| ₹68.00 | ₹70.74 | ₹68.00 | ₹70.44 | 3.38K (Cr) | |
| ₹69.99 | ₹69.99 | ₹66.30 | ₹67.38 | 447.00 (Cr) | |
| ₹67.80 | ₹69.00 | ₹67.49 | ₹68.80 | 1.57K (Cr) | |
| ₹66.64 | ₹66.64 | ₹66.54 | ₹66.55 | 366.00 (Cr) | |
| ₹63.55 | ₹65.98 | ₹63.55 | ₹65.02 | 410.00 (Cr) |
GKB Ophthalmics Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹63.73 | ₹63.73 | ₹60.60 | ₹60.70 | -4.75% | |
| ₹69.00 | ₹70.74 | ₹60.61 | ₹63.73 | -7.64% | |
| ₹51.51 | ₹76.90 | ₹51.51 | ₹68.49 | +32.96% | |
| ₹55.50 | ₹64.99 | ₹51.05 | ₹52.50 | -5.41% | |
| ₹58.00 | ₹74.50 | ₹51.45 | ₹58.86 | +1.48% | |
| ₹50.99 | ₹60.00 | ₹48.15 | ₹57.11 | +12.00% | |
| ₹59.80 | ₹61.35 | ₹45.25 | ₹51.24 | -14.31% | |
| ₹69.36 | ₹69.36 | ₹54.35 | ₹59.62 | -14.04% | |
| ₹67.30 | ₹73.60 | ₹62.35 | ₹67.67 | +0.55% | |
| ₹79.80 | ₹83.90 | ₹65.00 | ₹67.27 | -15.70% | |
| ₹77.00 | ₹91.70 | ₹74.00 | ₹77.42 | +0.55% | |
| ₹75.99 | ₹80.00 | ₹70.00 | ₹73.10 | -3.80% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap turnaround story built on fumes; avoid until real cash flow emerges.
WHAT'S HAPPENING NOW (last 2-4 weeks)
GKB Ophthalmics has been primarily focused on regulatory compliance and corporate governance. Key activities include:
* Confirmation of non-applicability of SEBI circular for large corporates.
* Submission of compliance certificates under SEBI regulations.
* An independent directors meeting was held on March 18, 2026, covering board effectiveness, chairperson evaluation, and information flow.
CORE STORY (THE REAL GAME)
- Recent positive quarterly results (revenue and profit growth)
- Independent directors meeting suggests focus on corporate governance
- Overall positive sentiment in the medical equipment sector
- Sustained profitability in upcoming quarters
- Significant order wins or contract announcements
- Successful expansion into new markets
- Micro-cap: Illiquidity risk is very high.
- Negative ROE, ROCE, and Free Cash Flow.
- High debt/equity ratio and negative interest coverage.
Promoter holding steady at 51.06%. No significant FII/DII activity [cite: brief].
Indian medical devices sector has strong momentum, but GKB needs to prove it can capture this growth.
No major news found after live search.
No: Free Cash Flow 5Y: ₹-3.82 Cr [cite: brief]
Needs to demonstrate consistent profitability and cash flow generation over the next 3-6 months. Monitor closely for signs of financial distress or governance issues.
Primary Thesis Risk
Inability to sustain profitability will lead to a collapse in the stock price.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
GKB Ophthalmics Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
GKB Ophthalmics Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GKB across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (231.15%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (15.42%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (13.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (51.06%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-12.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-6.00%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.15%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Weak Interest Coverage (-0.65x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-3.82 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.79%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
GKB Ophthalmics Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare GKB Ophthalmics Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
GKB Ophthalmics LtdGKB Ophthalmics...Selected✓ GKB • 533212 | 29.9/100 | ₹60.70₹61 | ₹29.99₹29.99 | — — | -12.66%Poor -12.66% Poor | -6.00%Poor -6.00% Poor | 0.28Excellent 0.3 Excellent | — — | 13.24%Good 13.24% Good | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 60.7/100 | ₹1330.30₹1330 | ₹19506.20₹19506.20 | 53.89Average 53.9 Average | 15.77%Good 15.77% Good | 20.08%Excellent 20.08% Excellent | 0.08Excellent 0.1 Excellent | 28.38%Excellent 28.38% Excellent | 19.44%Excellent 19.44% Excellent | 0.18% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 31.7/100 | ₹37.46₹37 | ₹3162.93₹3162.93 | 157.52Average 157.5 Average | 0.70%Poor 0.70% Poor | 1.08%Poor 1.08% Poor | 0.08Excellent 0.1 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 68.7/100 | ₹243.13₹243 | ₹1488.44₹1488.44 | 57.78Average 57.8 Average | 21.88%Excellent 21.88% Excellent | 19.20%Good 19.20% Good | 0.04Excellent 0.0 Excellent | 57.51%Excellent 57.51% Excellent | 9.81%Good 9.81% Good | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 42.1/100 | ₹496.70₹497 | ₹1363.11₹1363.11 | 50.06Average 50.1 Average | 30.08%Excellent 30.08% Excellent | 31.14%Excellent 31.14% Excellent | 0.56Good 0.6 Good | — — | — — | 0.00% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 13.8/100 | ₹214.98₹215 | ₹1224.98₹1224.98 | 59.58Average 59.6 Average | 4.75%Poor 4.75% Poor | 6.91%Poor 6.91% Poor | 0.63Good 0.6 Good | — — | — — | 0.00% |
60.3/100 | ₹173.00₹173 | ₹633.93₹633.93 | 25.77Average 25.8 Average | 36.78%Excellent 36.78% Excellent | 31.12%Excellent 31.12% Excellent | 0.53Good 0.5 Good | 90.06%Excellent 90.06% Excellent | 61.82%Excellent 61.82% Excellent | 0.00% | |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 68.5/100 | ₹408.00₹408 | ₹521.17₹521.17 | 26.18Average 26.2 Average | 18.74%Good 18.74% Good | 25.25%Excellent 25.25% Excellent | 0.00Excellent 0.0 Excellent | 29.49%Excellent 29.49% Excellent | 22.80%Excellent 22.80% Excellent | 0.23% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 61.2/100 | ₹413.00₹413 | ₹354.57₹354.57 | 34.23Average 34.2 Average | 13.58%Average 13.58% Average | 16.35%Good 16.35% Good | 0.43Excellent 0.4 Excellent | 74.11%Excellent 74.11% Excellent | 13.69%Good 13.69% Good | 0.00% |
47.7/100 | ₹187.00₹187 | ₹294.37₹294.37 | 32.71Average 32.7 Average | 13.56%Average 13.56% Average | 18.45%Good 18.45% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 36/100 | ₹272.15₹272 | ₹292.61₹292.61 | 71.19Average 71.2 Average | -1.12%Poor -1.12% Poor | -0.90%Poor -0.90% Poor | 0.03Excellent 0.0 Excellent | — — | 1.98%Average 1.98% Average | 0.00% |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price19506.20 Cr
- Fischer Medical Ventures Ltd share price3162.93 Cr
- Laxmi Dental Ltd share price1488.44 Cr
- OSEL DEVICES LIMITED share price1363.11 Cr
- Tarsons Products Ltd share price1224.98 Cr
GKB Ophthalmics Ltd Dividend History
Annual cash dividends paid by GKB — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2023 | ₹0.00 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
GKB Ophthalmics Ltd Quarterly Performance
Latest quarterly metrics for GKB — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
15.42%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
231.15%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.24%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
GKB Ophthalmics Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GKB — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
GKB Ophthalmics Ltd Financial Statements
Annual income statement, balance sheet and cash flow for GKB Ophthalmics Ltd (GKB) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for GKB Ophthalmics Ltd
About GKB (GKB Ophthalmics Ltd)
GKB Ophthalmics Ltd is a pioneering force in the global landscape of ophthalmic lens manufacturing, dedicated to enhancing vision and transforming lives through precision optics. W...ith a legacy spanning decades, GKB has established itself as a trusted provider of high-quality lens solutions, catering to the diverse needs of eye care professionals and patients worldwide. At the heart of GKB's success lies an unwavering commitment to innovation, leveraging cutting-edge technology and advanced materials to develop lenses that deliver superior clarity, comfort, and visual performance. From meticulously crafted single vision lenses to sophisticated progressive designs, GKB's comprehensive portfolio embodies excellence in optical engineering. Driven by a passion for precision and patient satisfaction, GKB Ophthalmics Ltd adheres to rigorous quality control standards throughout its manufacturing processes. Every lens undergoes meticulous inspection and testing to ensure optimal performance and compliance with international regulatory requirements. GKB understands that vision is precious and they strive to deliver products that meet the highest standards of quality and accuracy. The company's state-of-the-art facilities are equipped with advanced machinery and staffed by a team of highly skilled technicians and engineers, ensuring seamless production and consistent product quality. GKB is also committed to sustainable practices, minimizing environmental impact and promoting responsible manufacturing. Beyond manufacturing, GKB Ophthalmics Ltd fosters strong partnerships with eye care professionals, providing comprehensive support and educational resources to empower them in delivering exceptional patient care. The company believes in building lasting relationships based on trust, collaboration, and mutual success. GKB's global presence extends to numerous countries, enabling it to serve a diverse customer base and contribute to the advancement of eye care globally. With a vision to shape the future of optics, GKB Ophthalmics Ltd remains dedicated to innovation, quality, and customer satisfaction, continually striving to enhance vision and improve the lives of people around the world.
Company Details
Key Leadership
Corporate Events
Latest News
GKB Share Price: Frequently Asked Questions
What is the current share price of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd (GKB) trades at ₹60.70 on NSE and BSE. Market cap ₹29.99 (Cr). Educational data only.
What is the P/E ratio of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has a P/E of N/Ax vs industry average 47.87x.
What is the Bull Run score for GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has a Bull Run score of 29.9/100 based on 25+ financial parameters.
Does GKB Ophthalmics Ltd pay dividends?
GKB Ophthalmics Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has ROE of -12.66%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has debt-to-equity of 0.28.
Is GKB Ophthalmics Ltd a good investment?
Bull Run gives GKB Ophthalmics Ltd a score of 29.9/100. This is not investment advice — consult a SEBI-registered advisor.